Clinical trials
Multiple Sclerosis trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 4 |
| 2013 | 3 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 4 |
| Sanofi | 3 |
| Novartis | 2 |
| Novartis Pharmaceuticals | 2 |
| EMD Serono | 1 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Ono Pharma USA Inc | 1 |
| Teva Takeda Pharma Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 15 |
| Multiple Sclerosis, Relapsing-Remitting | 5 |
| Demyelinating Diseases | 2 |
| Autoimmune Diseases | 1 |
| Immune System Diseases | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Nervous System Diseases | 1 |
| Optic Neuritis | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.